September 21, 2025 - 00:14

The sci-fi classic Blade Runner (1982) shares a number of thematic analogies with the BlackRock Science and Technology Term Trust. Just as the film explores the complexities of artificial intelligence and humanity, the Trust navigates the intricate landscape of technological investments. With a focus on innovation, the Trust aims to provide investors with exposure to cutting-edge companies that are shaping the future.
Recently, the Trust has garnered attention for its impressive dividend yield of 11.9%. This substantial return reflects the Trust's strategic investments in sectors that are poised for growth, similar to the futuristic advancements depicted in Blade Runner. The film's exploration of ethical dilemmas and the implications of technology resonates with investors who are keen on understanding the potential risks and rewards associated with modern investments.
As the Trust continues to adapt to the ever-evolving market, it stands as a testament to the intersection of finance and technology, much like the narrative of Blade Runner challenges our perceptions of reality and existence.
August 9, 2026 - 18:31
County agenda features tax, technology and fairgroundsThe meeting will center on how to fund the ongoing fairgrounds project, a long-discussed priority for the county. Officials are expected to review the latest cost estimates and possible revenue...
August 9, 2026 - 00:24
‘AI slop’ crackdown: LinkedIn, Snap target low-quality gen-AI contentSocial platforms are starting to push back against the flood of generic, machine-generated posts, but they are doing so carefully. LinkedIn and Snap have both announced new measures aimed at...
August 8, 2026 - 05:47
Why GigaCloud Technology (GCT) Is Up 21.7% After Strong Q2 Results And New Buyback PlanGigaCloud Technology saw its stock surge 21.7% in early trading following the release of its second-quarter financial results and the announcement of a new capital return program. The company...
August 7, 2026 - 22:40
As FDA Approves First-Ever mRNA Flu Vaccine For Older Adults, Past KFF Polling Showed Most In This Age Group Were Uncertain About the Technology’s SafetyOn August 5, 2026, the U.S. Food and Drug Administration gave the green light to the first messenger RNA flu vaccine for adults aged 50 and older. The decision came after a clinical trial involving...